Molecule AI is revolutionizing drug discovery with AI-powered solutions, accelerating research, reducing costs, and enabling faster development of life-saving therapies globally. During an exclusive interaction with NCN Magazine, Mr. Somraj Bhattacharjee, Head of Sales, Molecule AI, shares how AI is transforming drug discovery by making it faster, smarter, and cost-efficient.
Can you tell us about Molecule AI and its core focus?
At Molecule AI, we focus on transforming the drug discovery process using artificial intelligence. Our goal is to make drug discovery faster, more accessible, and significantly more cost-efficient. By leveraging advanced AI models and proprietary platforms like MoleculeGEN, we help pharmaceutical companies accelerate the identification and development of promising therapeutic candidates.
How does AI help improve the traditional drug discovery process?
Traditional drug discovery is time-consuming and expensive, often taking years before reaching preclinical stages. Our AI-driven approach speeds up this process by designing new molecules, predicting their behavior, and optimizing leads with high accuracy. This reduces the time, cost, and complexity involved, enabling faster progress toward life-saving treatments.
What makes Molecule AI’s approach unique?
Our strength lies in our team of highly skilled data scientists, engineers, and researchers from leading global institutions, combined with strong in-house research capabilities. We develop innovative AI models that enable De Novo drug design, accurate ADMET prediction, and streamlined R&D workflows. Importantly, all of this innovation is driven from India, contributing to global pharmaceutical advancements.
What is your broader vision for the future?
We envision a future where AI enables faster discovery, reduces development risks, and makes advanced therapies more affordable and accessible worldwide.
Covered By: NCN MAGAZINE / Molecule AI
If you have an interesting Article / Report/case study to share, please get in touch with us at editors@roymediative.com , roy@roymediative.com, 9811346846/ 9625243429
